Universal Biosensors Inc (UBI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Universal Biosensors Inc (UBI) has a cash flow conversion efficiency ratio of -0.301x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.13 Million ≈ $-1.51 Million USD) by net assets (AU$7.08 Million ≈ $5.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Universal Biosensors Inc (UBI) market capitalisation for the company's overall valuation and market capitalisation.
Universal Biosensors Inc - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Universal Biosensors Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Universal Biosensors Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Universal Biosensors Inc ranked by their cash flow conversion efficiency. Explore UBI cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Khandwala Securities Limited
NSE:KHANDSE
|
-0.051x |
|
8I Holdings Ltd
AU:8IH
|
-0.057x |
|
MacDonald Mines Exploration Ltd
V:BMK
|
-0.004x |
|
amalphi ag
F:AMI
|
N/A |
|
Colabor Group Inc.
TO:GCL
|
0.101x |
|
Timah Resources Ltd
AU:TML
|
0.007x |
|
Golden Goliath Resources Ltd.
V:GNG
|
-0.603x |
|
Kingsland Minerals Ltd
AU:KNG
|
-0.081x |
Annual Cash Flow Conversion Efficiency for Universal Biosensors Inc (2002–2024)
The table below shows the annual cash flow conversion efficiency of Universal Biosensors Inc from 2002 to 2024. View UBI live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$17.37 Million ≈ $12.29 Million |
AU$-12.30 Million ≈ $-8.70 Million |
-0.708x | +5.51% |
| 2023-12-31 | AU$19.51 Million ≈ $13.80 Million |
AU$-14.62 Million ≈ $-10.34 Million |
-0.749x | -32.99% |
| 2022-12-31 | AU$26.09 Million ≈ $18.46 Million |
AU$-14.70 Million ≈ $-10.40 Million |
-0.563x | -57.19% |
| 2021-12-31 | AU$27.61 Million ≈ $19.53 Million |
AU$-9.90 Million ≈ $-7.00 Million |
-0.358x | -64.20% |
| 2020-12-31 | AU$37.98 Million ≈ $26.87 Million |
AU$-8.29 Million ≈ $-5.87 Million |
-0.218x | -129.81% |
| 2019-12-31 | AU$45.39 Million ≈ $32.12 Million |
AU$33.24 Million ≈ $23.52 Million |
0.732x | +2003.00% |
| 2018-12-31 | AU$50.67 Million ≈ $35.85 Million |
AU$1.76 Million ≈ $1.25 Million |
0.035x | -94.88% |
| 2017-12-31 | AU$12.77 Million ≈ $9.04 Million |
AU$8.69 Million ≈ $6.15 Million |
0.681x | +27.96% |
| 2016-12-31 | AU$13.25 Million ≈ $9.38 Million |
AU$7.05 Million ≈ $4.99 Million |
0.532x | +285.32% |
| 2015-12-31 | AU$13.26 Million ≈ $9.38 Million |
AU$1.83 Million ≈ $1.29 Million |
0.138x | +150.33% |
| 2014-12-31 | AU$19.74 Million ≈ $13.97 Million |
AU$-5.41 Million ≈ $-3.83 Million |
-0.274x | +51.04% |
| 2013-12-31 | AU$29.68 Million ≈ $21.00 Million |
AU$-16.63 Million ≈ $-11.77 Million |
-0.560x | -568.20% |
| 2012-12-31 | AU$39.37 Million ≈ $27.86 Million |
AU$-3.30 Million ≈ $-2.34 Million |
-0.084x | +58.99% |
| 2011-12-31 | AU$35.02 Million ≈ $24.78 Million |
AU$-7.16 Million ≈ $-5.07 Million |
-0.204x | -50.48% |
| 2010-12-31 | AU$47.22 Million ≈ $33.41 Million |
AU$-6.41 Million ≈ $-4.54 Million |
-0.136x | -218.81% |
| 2009-12-31 | AU$51.31 Million ≈ $36.31 Million |
AU$5.87 Million ≈ $4.15 Million |
0.114x | +177.99% |
| 2008-12-31 | AU$48.70 Million ≈ $34.46 Million |
AU$-7.14 Million ≈ $-5.05 Million |
-0.147x | +5.45% |
| 2007-12-31 | AU$60.07 Million ≈ $42.51 Million |
AU$-9.31 Million ≈ $-6.59 Million |
-0.155x | -146.03% |
| 2006-12-31 | AU$37.05 Million ≈ $26.21 Million |
AU$-2.33 Million ≈ $-1.65 Million |
-0.063x | -209.68% |
| 2005-12-31 | AU$3.93 Million ≈ $2.78 Million |
AU$226.00K ≈ $159.91K |
0.057x | +11.37% |
| 2004-12-31 | AU$3.97 Million ≈ $2.81 Million |
AU$205.00K ≈ $145.05K |
0.052x | -79.48% |
| 2002-12-31 | AU$1.36 Million ≈ $962.29K |
AU$342.00K ≈ $241.99K |
0.251x | -- |
About Universal Biosensors Inc
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more